An unexpected switch in peptide binding mode: from simulation to substrate specificity.

J Biomol Struct Dyn

a Faculty of Chemistry and Pharmacy, Institute of General, Inorganic and Theoretical Chemistry , University Innsbruck, Innrain 82, Innsbruck A-6020 , Austria.

Published: November 2018

AI Article Synopsis

  • A molecular dynamics simulation lasting ten microseconds revealed an unexpected change in how a kallikrein-related peptidase 7 peptide complex binds, showing a 180° rotation around the P1 residue.
  • The binding pose shifts to occupy the prime side region instead of the non-prime side, and this new binding mode is analyzed through various molecular properties and compared with existing inhibitors.
  • The study also incorporates in silico mutagenesis to investigate the specificity of the binding on the prime side, providing valuable insights that could aid in the development of targeted inhibitors for treating skin diseases and cancer.

Article Abstract

A ten microsecond molecular dynamics simulation of a kallikrein-related peptidase 7 peptide complex revealed an unexpected change in binding mode. After more than two microseconds unrestrained sampling we observe a spontaneous transition of the binding pose including a 180° rotation around the P1 residue. Subsequently, the substrate peptide occupies the prime side region rather than the cognate non-prime side in a stable conformation. We characterize the unexpected binding mode in terms of contacts, solvent-accessible surface area, molecular interactions and energetic properties. We compare the new pose to inhibitor-bound structures of kallikreins with occupied prime side and find that a similar orientation is adopted. Finally, we apply in silico mutagenesis based on the alternative peptide binding position to explore the prime side specificity of kallikrein-related peptidase 7 and compare it to available experimental data. Our study provides the first microsecond time scale simulation data on a kallikrein protease and shows previously unexplored prime side interactions. Therefore, we expect our study to advance the rational design of inhibitors targeting kallikrein-related peptidase 7, an emerging drug target involved in several skin diseases as well as cancer.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6334781PMC
http://dx.doi.org/10.1080/07391102.2017.1407674DOI Listing

Publication Analysis

Top Keywords

prime side
16
binding mode
12
kallikrein-related peptidase
12
peptide binding
8
binding
5
side
5
unexpected switch
4
peptide
4
switch peptide
4
mode simulation
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!